Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery

Clinical Research in Cardiology

Volumn 100, Issue 7, 2011, Pages 595-602

  Loukanov, Tsvetomir ^a   Bucsenez, Dietrich ^b   Springer, Wolfgang ^b   Sebening, Christian ^a   Rauch, Helmut ^b   Roesch, Eva ^b   Karck, Matthias ^a   Gorenflo, Matthias ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Children; Congenital heart disease; Pulmonary hypertension; Surgery

Indexed keywords

CEPHALOSPORIN; FLUCLOXACILLIN; ILOPROST; IMMUNOGLOBULIN; NITRIC OXIDE; THROMBOCYTE CONCENTRATE;

AEROSOL; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BLEEDING; CARDIOPULMONARY BYPASS; CHRONIC RESPIRATORY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HEART LEFT RIGHT SHUNT; HUMAN; HYPERTENSIVE CRISIS; INFANT; LUNG ARTERY PRESSURE; MORTALITY; OPEN STUDY; PATIENT SAFETY; PERIOPERATIVE PERIOD; PILOT STUDY; PNEUMONIA; PULMONARY HYPERTENSION; PULMONARY HYPERTENSIVE CRISIS; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRISOMY 21; WEANING;

ADMINISTRATION, INHALATION; BRONCHODILATOR AGENTS; CARDIOPULMONARY BYPASS; HEART DISEASES; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; INFANT; NITRIC OXIDE; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 80051790964     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0284-5     Document Type: Article

References (18)

1. Loukanov T, Arnold R, Gross J, Sebening C, Klimpel H, Eicjorn J, Hoss K, Ulmer HE, Kark M, Gorenflo M (2008) Endothelin-1 and asymmetric dimethylarginine in children with left-to-right shunt after intracardiac repair. Clin Res Cardiol 97(6):383-388
2. Lindberg L, Olsson AK, Jogi P, Jonmarker C (2002) How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg 123:1155-1163
3. Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufiero TX, Sun K, Sekine E, Brown JW (1996) Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. J Thorac Cardiovasc Surg 112(6):1600-7; 1607-9
4. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS (2001) Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised doubleblind study Lancet 357(9255):558-9
5. Day RW, Hawkins JA, McGough EC, Crezeé KL, Orsmond GS (2000) Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 69(6):1907-1912
6. Bizzarro M, Gross I (2005) Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database Syst Rev 19:(4)
7. Macrae DJ, Field D, Mercier JC, Møller J, Stiris T, Biban P, Cornick P, Goldman A, Göthberg S, Gustafsson LE, Hammer J, Lönnqvist PA, Sanchez-Luna M, Sedin G, Subhedar N (2004) Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Intensive Care Med 30(3):372-380 (Pubitemid 38375609)
8. Limsuwan A, Wanitkul S, Khosithset A, Attanavanich S, Samankatiwat P (2008) Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease. Int J Cardiol 129(3):333-338
9. Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M (2001) Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 103:544-548 (Pubitemid 32116239)
10. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK (1987) Primary pulmonary hypertension: a nationwide prospective study. Ann Intern Med 107:216-223 (Pubitemid 17137857)
11. Bando K, Vijayaraghavan P, Turrentine MW, Sharp TG, Ensing GJ, Sekine Y, Szekely L, Morelock RJ, Brown JW (1997) Dynamic changes of endothelin-1, nitric oxide, and cyclic GMP in patients with congenital heart disease. Circulation 96(9): 346-51
12. Pauli C, Fakler U, Genz T, Hennig M, Lorenz H-P, Hess J (2002) Cardiac output determination in children: equivalence of the transpulmonary thermodilution method to the direct FICK principle. Intensive Care Med 28:947-952 (Pubitemid 34762232)
13. Vargo TA (1997) Cardiac catheterization: hemodynamic measurements. In: Garson A, Bricker Jt, Fisher DJ, Neish SR (eds) The science and practice of pediatric cardiology, 2nd edn. Williams&Wilkins, Baltimore, pp 961-993
14. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ (1994) Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 108(3):487-494 (Pubitemid 24299673)
15. Gorenflo M, Bettendorf M, Brockmeier K, Ulmer HE (2000) Pulmonary vasoreactivity and vasoactive mediators in children with pulmonary hypertension. Z Kardiol 89:1000-1008
16. Ivy DD, Doran AK, Smith KJ, Mallory GB Jr, Beghetti M, Barst RJ, Brady D, Law Y, Parker D, Claussen L, Abman SH (2008) Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am Coll Cardiol 51(2):161-9
17. Limsuwan A, Khosithseth A, Wanichkul S, Khowsathit P (2009) Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Catheter Cardiovasc Interv 73(1): 98-104
18. Högman M, Frostell CG, Hedenström H, Hedenstierna G (1993) Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 148(1):1474-1478